Hua Xia Healthcare Holdings Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hua Xia Healthcare Holdings Limited with three other
companies in this sector in Hong Kong:
Qianhai Health Holdings Ltd
sales of 354.39 million Hong Kong Dollars [US$45.50 million]
of which 62%
was Cultivated ginseng),
Pa Shun Pharmaceutical International Hldg Ltd
(1.00 billion Hong Kong Dollars [US$128.89 million]
of which 90%
was Pharmaceutical distribution), and
Sinco Pharmaceuticals Holdings Ltd
(1.00 billion Hong Kong Dollars [US$128.64 million]
Hua Xia Healthcare Holdings Limited reported sales of HK$1.57 billion (US$202.16 million)
March of 2016.
decrease of 11.6%
versus 2015, when the company's sales were HK$1.78 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Hua Xia Healthcare Holdings Limited had sales
of HK$1.49 billion.
Contributing to the drop in overall sales was the 15.6% decline
in Pharmaceutical Wholesale, from HK$1.57 billion to HK$1.32 billion.
However, these declines were partially offset by the increase in sales of
Provision of General Hospital Services (up 18.1% to HK$252.84 million)